N
RMD icon

Numerai’s ResMed RMD Stock Holding History

Numerai’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$335K Buy
1,717
+286
+20% +$59.3K 0.03% 637
2026
Q1 		$321K Buy
1,431
+531
+59% +$132K 0.03% 633
2025
Q4 		$217K Buy
+900
New +$230K 0.03% 563
2025
Q2 		– Sell
-2,361
Closed -$529K – 611
2025
Q1 		$529K Buy
2,361
+594
+34% +$139K 0.1% 276
2024
Q4 		$404K Sell
1,767
-995
-36% -$240K 0.11% 249
2024
Q3 		$674K Buy
2,762
+1,397
+102% +$312K 0.18% 177
2024
Q2 		$261K Buy
+1,365
New +$277K 0.1% 256
2023
Q4 		– Sell
-31,058
Closed -$4.59M – 301
2023
Q3 		$4.59M Buy
+31,058
New +$5.62M 1.53% 9

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Numerai's RMD Position: Q2 2026 in Review

Numerai increased its ResMed (RMD) stake by 20% in Q2 2026, buying an estimated $59.3K and bringing the position to 1,717 shares worth $335K. The position accounts for 0.03% of the portfolio, ranked #637.

Numerai first reported a position in RMD in Q3 2023 and has held it in 8 quarters since. The position peaked at $4.59M in Q3 2023. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Numerai held 1,717 shares of ResMed worth $335K as of Q2 2026.
  • Numerai bought 286 ResMed shares in Q2 2026, an estimated $59.3K.
  • ResMed made up 0.03% of Numerai's portfolio in Q2 2026, its #637 holding.
  • Numerai first reported a position in ResMed in Q3 2023 and has held it in 8 quarters since.
  • Numerai's ResMed position peaked at $4.59M in Q3 2023.
  • 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Numerai's 13F filing for Q2 2026, filed 14 Aug 2026.